Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
10/2005
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1202986B1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
10/12/2005EP0794774B1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
10/12/2005CN1682320A Nonaqueous electrolyte, electrical double layer capacitors, and nonaqueous electrolyte secondary cells
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1680310A Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation
10/12/2005CN1680308A New 3-aryl-2-hydroxypropionic acid derivative I
10/12/2005CN1222501C Novel compounds
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/06/2005WO2005092845A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005WO2005092844A1 Nonpeptide inhibitors of matrix metalloproteinases
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005092830A1 Optically active transition metal/diamine complex and process for producing optically active alcohol with the same
10/06/2005WO2005092825A1 Process for production of optically active alcohols
10/06/2005WO2005092316A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005WO2005073216A3 Hcv ns-3 serine protease inhibitors
10/06/2005US20050222460 Method for treating an imide organic solution bearing a sulphonyl group
10/06/2005US20050222448 N-sulphonylaminoacetonitriles having pesticidal properties
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050222254 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005US20050222215 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005US20050221982 Heat sensitive recording material
10/06/2005CA2560526A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005CA2557794A1 Opioid receptor antagonists
10/05/2005EP1581511A1 Ccr8 inhibitors
10/05/2005EP1581474A1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1077936B1 Novel analogs of 16-hydroxyeicosatetraenoic acid
10/05/2005CN1679200A Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/05/2005CN1221504C Perfluoroisopropylbenzene derivatives
10/04/2005US6951887 Lipoic acid derivatives and their use in treatment of disease
09/2005
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090296A2 N-substituted benzene sulfonamides
09/29/2005WO2005090288A1 Phenylaminoethanol derivates as beta2 receptor agonists
09/29/2005WO2005090283A1 Methods of amination
09/29/2005WO2005089815A2 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
09/29/2005WO2005089511A2 Novel pharmaceutical forms, and methods of making and using the same
09/29/2005WO2005089269A2 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
09/29/2005WO2005073195A3 Hcv ns-3 serine protease inhibitors
09/29/2005WO2005055286A3 Zwitterionic compounds and photovoltaic cells containing same
09/29/2005WO2005028516A3 Albumin-binding derivatives of therapeutic peptides
09/29/2005US20050215825 Hydroaminomethylation of an olefin, a primary or secondary amine with a catalyst of a neutral rhodium-monodentate phosphite ligand complex prepared by contacting a neutral rhodium procatalyst with a monodentate phosphite ligand; chemical intermediate for ibutilide, terfenadine, and fexofenadine
09/29/2005US20050215819 Method of producing an amide
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215642 Aromatic guanidine compound; antitumor agents; anticancer agents; for the treatment of breast cancer
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050211292 Zwitterionic compounds and photovoltaic cells containing same
09/29/2005DE102004011720A1 Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie Radio Halogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2559533A1 Phenylaminoethanol derivatives as beta2 receptor agonists
09/29/2005CA2559047A1 N-substituted benzene sulfonamides
09/28/2005EP1578898A2 Nad synthetase inhibitors and uses thereof
09/28/2005EP1578721A2 Processes for the preparation of substituted isoxazoles and 2-isoxazolines
09/28/2005EP1578717A2 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1675168A Propionic acid derivatives and their use as hPPARs activators
09/27/2005US6949672 Method for producing arylsulphonic acid isocyanates
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005CA2299355C Aryloxyarylsulfonylamino hydroxamic acid derivatives
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005070871A3 Amino alcohol derivatives and their activity as renin inhibitors
09/22/2005WO2005004802A3 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
09/22/2005US20050209333 Malonamic acids and derivatives thereof as thyroid receptor ligands
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/21/2005EP1577292A1 Phenylaminoethanol derivatives as beta2 receptor agonists
09/21/2005EP1577291A1 Phenylethanolamine derivatives as beta-2 agonists
09/21/2005EP1575914A1 Aromatic derivatives as hiv aspartyl protease inhibitors
09/21/2005EP1575903A1 Compounds for the inhibition of rotamases
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1294679B1 Beta-amino acid nitrile derivatives
09/21/2005CN1672094A Electrolytes for electrooptic devices comprising ionic liquids
09/21/2005CN1219764C W-carboxyaryl substituted diphenyl ureas as RAF kinase inhibitors
09/21/2005CN1219756C Process for preparing biphenyl compounds
09/15/2005WO2005085189A2 Analogues of congo red and evaluation of their anti-prion activity
09/15/2005WO2005085188A2 Compounds and methods for anti-tumor therapy
09/15/2005WO2005067502A3 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
09/15/2005WO2004099170A3 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
09/15/2005WO2004029019A8 Compounds for the treatment of alzheimer’s disease
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/14/2005EP1572678A2 Substituted n-phenyl sulfonamide bradykinin antagonists
09/14/2005EP1392643B1 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005CN1668291A Substituted phenylsulfonamide inhibitors of beta amyloid production
09/13/2005US6943253 6-phenylpyrrolopyrimidinedione derivatives
09/13/2005US6943170 N-cycloalkylglycines as HIV protease inhibitors
09/13/2005CA2279276C Arylsulfonylamino hydroxamic acid derivatives
09/09/2005WO2005082845A1 Novel therapies with somatostatin receptor agonists
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 177